
Washington DC: A preclinical study conducted by Weill Cornell Medicine researchers reveals that a certain human genetic variant of a receptor that increases insulin release may help individuals be more resistant to obesity. The researchers revealed that this version operates differently in the cell, which may lead to more effective metabolism.